COMMUNIQUÉS West-GlobeNewswire

Triumph Steps Scales Proven Transformative Coaching Certification for Mental Health Professionals
08/10/2025
New Certification Empowers Therapists and Coaches to Reclaim Purpose and Expand Impact Miami, Florida, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Triumph Steps , a leader in emotional literacy education, today announced the [...]
Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
08/10/2025
Company to share eight poster presentations highlighting advanced diagnostic tools to gain critical insights and shorten the diagnostic odyssey HOUSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical [...]
Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators
08/10/2025
MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an [...]
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis
08/10/2025
- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of Multiple Sclerosis (MS [...]
Confo Therapeutics Awarded VLAIO Grant for Development of Ultra-Long-Acting Antibody-Based GPCR Therapeutics in Endocrine and Metabolic Conditions
08/10/2025
Ghent, Belgium – October 8, 2025 – Confo Therapeutics , a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has secured a EUR 1 million grant from Flanders [...]
Immuron Submits IMM-529 IND to FDA
08/10/2025
Key Points Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical [...]
FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial
08/10/2025
FDA clears path for Phase 3 testing following positive Type B meeting Regulatory alignment confirms preclinical data sufficient for pivotal initiation Phase 3 to include two 28-day trials and a 12-month safety extension [...]
ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress
08/10/2025
Study showed targeted tumor uptake with low healthy organ exposure in broad cohort of 207 patients Supports therapeutic potential of ITM’s proprietary targeted radiotherapeutic agent Abstract receives prestigious EANM [...]
Newcastle Set To Benefit From New Technology to Diagnose Disease
08/10/2025
Newcastle University has entered into a lease agreement with Curium for a new site dedicated to the manufacture of cutting-edge diagnostic technologies for diseases such as cancer. The facility will be operated by [...]
Oxford Set To Benefit From New Technology to Diagnose Disease
08/10/2025
Curium will shortly open a new facility to manufacture cutting-edge diagnosis technology for diseases like cancer at the Churchill Hospital site, part of Oxford University Hospitals NHS Foundation Trust. Curium is a [...]
Dr. Anita Gupta of the University of California, Riverside, named the 2025 Recipient of the Arnold P. Gold Humanism in Medicine Award
08/10/2025
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Dr. Anita Gupta, a professor of medicine at UC Riverside, has been awarded the 2025 Arnold P. Gold Humanism in Medicine Award. This prestigious honor recognizes her [...]
CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies
08/10/2025
Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in a within-subject analysis in participants with low likelihood of having [...]
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
08/10/2025
New patents extend protection for Anaphylm™ into 2037 Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and only oral medication for the rescue treatment of severe allergic reactions [...]
LUKE Taps Major General Thomas Solhjem to Chair Newly Established Advisory Board to Guide Efforts to Help America’s Heroes Flourish
08/10/2025
ROCKLEDGE, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the U.S. Government and a national partner in advancing human flourishing, has announced that [...]
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
08/10/2025
AlphaMedix TM ( 212 Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedix TM showed [...]
Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR
08/10/2025
EINDHOVEN, Pays-Bas, 08 oct. 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société leader dans le domaine des neurotechnologies visant au développement de thérapies innovantes destinées à la [...]
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
08/10/2025
EINDHOVEN, the Netherlands, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide
08/10/2025
October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam, the Netherlands – [...]
Macomics Announces Neurodegeneration and Neuroinflammation Applications of ENIGMAC Drug Discovery Platform
08/10/2025
EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in neurodegeneration and [...]

Pages